ACURX PHARMACEUTICALS INC (ACXP)

US00510M1045 - Common Stock

2.17  +0.05 (+2.36%)

After market: 2.2 +0.03 (+1.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash
7.47M9.11M12.96M3.18M2.48M
Receivables
129.16KN/AN/AN/AN/A
Other Current Assets
105.78K260.00K300.00K50.00K50.00K
Total Current Assets
7.71M9.38M13.25M3.22M2.53M
 
Non-Current Assets
Total Non-Current Assets
0.000.000.000.000.00
 
TOTAL ASSETS
7.71M9.38M13.25M3.22M2.53M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/A0.0020.00K0.00
Accrued Expenses
3.04M2.03M780.00K460.00K1.25M
Accounts Payable
3.81K30.00K60.00K0.000.00
Other Current Liabilities
N/AN/AN/A0.00450.00K
Total Current Liabilities
3.04M2.06M840.00K470.00K1.71M
 
Non-Current Liabilities
Long Term Debt
0.000.000.0050.00K0.00
Total Non-Current Liabilities
0.000.000.0050.00K0.00
 
TOTAL LIABILITIES
3.04M2.06M840.00K520.00K1.71M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-53.22M-38.64M-26.55M-13.80M-9.20M
Additional Paid In Capital
57.87M45.94M38.95MN/AN/A
Common Shares
14.47K10.00K10.00K16.50M10.02M
Shares Outstanding
14.47M11.63M10.22M9.54M9.54M
Tangible Book Value per Share
0.320.631.210.280.09
Total Shareholders' Equity
4.67M7.32M12.41M2.70M820.00K
 
TOTAL LIABILITIES AND EQUITY
7.71M9.38M13.25M3.22M2.53M
 
Statistics
Debt/Equity
N/AN/AN/A0.02N/A
Current Ratio
2.534.5515.776.851.48
Return On Assets (ROA)
-189.10%-128.89%-96.23%-142.86%-234.39%
Return On Equity (ROE)
-312.38%-165.16%-102.74%-170.37%-723.17%

All data in USD

Charts